The number on the scale is going down. But without deliberate intervention, a significant portion of GLP-1 weight loss comes from muscle, not fat — and this changes the metabolic outcome completely.
By Dr. Teja V. Surapaneni, MD, MS • Board-Certified Internal Medicine • May 2026
The number on the scale is going down. That is the goal. But what is actually decreasing matters enormously — and without deliberate intervention, a significant portion of GLP-1 weight loss comes from muscle, not fat. This changes the metabolic outcome completely.
In the SURMOUNT-1 trial for tirzepatide, participants lost an average of 22.5% of total body weight at the highest dose. Body composition analysis from the trial showed that approximately 25–38% of weight lost was lean mass — muscle, bone mineral density, and water — rather than fat mass.
The STEP trials for semaglutide showed similar proportions: roughly 30% of total weight lost was lean mass in patients who did not have a specific protein or exercise intervention.
To put this in concrete terms: a patient starting at 250 lbs who loses 50 lbs on tirzepatide without a protein and exercise strategy may lose 15–20 lbs of muscle. Muscle is metabolically active tissue — losing it lowers resting metabolic rate, increases rebound weight gain risk when the medication is eventually stopped, reduces functional strength, and in older patients significantly increases fall and fracture risk.
GLP-1 medications work by reducing appetite and caloric intake — which is exactly the mechanism that causes muscle loss. Any time caloric intake drops significantly below expenditure, the body draws on both fat and protein stores for energy. Without a strong anabolic signal (resistance training + adequate dietary protein), the body has no metabolic reason to preferentially protect muscle over fat.
This is not unique to GLP-1 medications — it is a property of significant caloric restriction from any cause. GLP-1 medications accelerate it because the caloric reduction is deeper and more sustained than most patients achieve through willpower alone.
The evidence-based target during active weight loss on GLP-1:
This must be deliberate. GLP-1-suppressed appetite makes it easy to eat 800–1,000 calories per day with minimal protein. A 600-calorie salad with chicken provides more metabolic protection than 600 calories of crackers and cheese. Eat protein first at every meal before appetite suppression shuts you down.
Progressive resistance training (lifting, resistance bands, bodyweight with progressive overload) sends the strongest biological signal to retain muscle during caloric restriction. The threshold for effect is lower than most people expect:
Creatine monohydrate is the most evidence-backed supplement for muscle retention during weight loss. Mechanism: replenishes phosphocreatine in muscle, enabling greater training intensity. Meta-analyses show 1–2 kg lean mass advantage over placebo in resistance-trained individuals. Dose: 3–5g daily. Cheap, safe, and exceptionally well-studied. One of the few supplements that genuinely works.
The scale cannot tell you whether you are losing fat or muscle. A DEXA scan at baseline and after 6 months on therapy gives you objective data on exactly what is changing in your body composition. If lean mass is declining faster than expected, you have time to intervene — increase protein, increase training, consider reducing the pace of weight loss by adjusting dose.
Can you gain muscle while on semaglutide or tirzepatide? Yes — for patients new to resistance training (untrained), early gains in muscle alongside fat loss are achievable even in a caloric deficit, because the untrained stimulus response is strong. For experienced trainees, true muscle gain during a significant caloric deficit is unlikely, but preservation of existing muscle is achievable.
The patients who achieve the most meaningful outcomes on GLP-1 therapy are those who use it as a catalyst for body recomposition — losing fat while building or preserving muscle — rather than simply watching the scale decrease. The medication creates the caloric deficit. Protein and resistance training determine what that deficit comes from. The difference in long-term outcome between these two approaches is substantial.
This article is for informational purposes only and does not constitute medical advice. Always consult with a licensed physician before starting any medication.
No credit card required. Live MD consult included.